The preclinical discovery and development of opicapone for the treatment of Parkinson’s disease

Article

Abstract: Introduction: Opicapone (OPC) is a well-established catechol-O-methyltransferase (COMT) inhibitor th

Palabras claves:

dyskinesia, entacapone, Opicapone, Parkinson’s Disease, tolcapone

Autores:

Antoni Camins, Auladell C., Busquets O., Cano A., Ettcheto M., Folch J., Manzine P.R., Olloquequi J., Sanchez-Lopez E., Verdaguer E.

Fuentes:

scopus